share_log

Why LogicMark Shares Are Trading Lower By Around 25%; Here Are 20 Stocks Moving Premarket

Benzinga Real-time News ·  Jan 24, 2023 21:06

Gainers

  • Axcella Health Inc. (NASDAQ:AXLA) rose 71.7% to $0.7450 in pre-market trading after the company reported regulatory path to registration of AXA1125 for long COVID-19 fatigue.
  • Intelligent Bio Solutions Inc. (NASDAQ:INBS) shares rose 37.6% to $1.41 in pre-market trading. Intelligent Bio Solutions shares jumped 281% on Monday after the company announced it successfully completed the review of results from Milestone 7, a phase of its biosensor platform development.
  • Troika Media Group, Inc. (NASDAQ:TRKA) shares rose 29.3% to $0.2399 in pre-market trading after surging 15% on Monday.
  • Aridis Pharmaceuticals, Inc. (NASDAQ:ARDS) rose 20.5% to $1.41 in pre-market trading. Aridis Pharmaceuticals recently issued AR 501 Phase 2 trial update.
  • Evolve Transition Infrastructure LP (NYSE:SNMP) rose 19.5% to $0.2750 in pre-market trading after surging 53% on Monday.
  • Helbiz, Inc. (NASDAQ:HLBZ) rose 17.8% to $0.5020 in pre-market trading after jumping 109% on Monday. Helbiz said on Jan. 17, 2023, the company received letter of reprimand from Nasdaq listing qualifications staff.
  • HEXO Corp. (NYSE:HEXO) shares rose 14.2% to $1.77 in pre-market trading. HEXO recently regained compliance with Nasdaq minimum bid price requirement.
  • Aqua Metals, Inc. (NASDAQ:AQMS) rose 8.4% to $1.53 in pre-market trading. Aqua Metals recently regained compliance with Nasdaq listing requirements.
  • Bed Bath & Beyond Inc. (NASDAQ:BBBY) rose 6.2% to $3.12 in pre-market trading after dropping 12% on Monday. Bed Bath & Beyond recently received notice from NASDAQ regarding delayed quarterly report.
  • Yext, Inc. (NYSE:YEXT) rose 4.5% to $6.99 in pre-market trading after the company announced plans to cut size of the companyâ€s workforce by 8% of full-time employees as a part of its restructuring plan.

Losers

  • LogicMark, Inc. (NASDAQ:LGMK) fell 24.7% to $0.2749 in pre-market trading after the company reported pricing of $5.2 million underwritten public offering priced above market.
  • Verb Technology Company, Inc. (NASDAQ:VERB) shares fell 20.8% to $0.3075 in pre-market trading after the company reported a proposed underwritten public offering of common stock without warrants.
  • Leap Therapeutics, Inc. (NASDAQ:LPTX) fell 14.2% to $0.56 in pre-market trading after declining 9% on Monday. Leap Therapeutics recently agreed to acquire Flame Biosciences Inc, a privately-held biotechnology company, in an all-stock transaction.
  • Revelation Biosciences, Inc. (NASDAQ:REVB) fell 7.5% to $0.22 in pre-market trading.
  • NeuroBo Pharmaceuticals, Inc. (NASDAQ:NRBO) shares dropped 7.3% to $0.7395 in pre-market trading. NeuroBo Pharmaceuticals recently appointed Joseph Hooker as Interim Chief Executive Officer and President.
  • Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) fell 7.1% to $0.52 in pre-market trading. Spectrum Pharmaceuticals recently announced management changes.
  • Camber Energy, Inc. (NYSE:CEI) fell 7% to $2.13 in pre-market trading. Camber Energy agreed to acquire renewable diesel facility.
  • Greenidge Generation Holdings Inc. (NASDAQ:GREE) fell 6.6% to $0.92 in pre-market after gaining around 6% on Monday.
  • Lytus Technologies Holdings PTV. Ltd. (NASDAQ:LYT) shares fell 6.5% to $1.27 in pre-market trading after gaining around 5% on Monday.
  • Celyad Oncology SA (NASDAQ:CYAD) fell 5.3% to $1.96 in pre-market trading after gaining around 7% on Monday. Celyad Oncology recently issued an update on its Celyad 2.0 business strategy, which has been adopted and implemented over the last few months.

Now Read This: Markets Turn More Bullish Ahead Of Earnings

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment